In patients with persistent ISSNHL after systemic corticosteroid therapy, intratympanic corticosteroid injections resulted in limited hearing improvement. Despite the low risks associated with this therapy, its routine use should be considered on a case-by-case evaluation.
Götting et al. (Tue,) studied this question.